Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

FEB 06, 2014 - The Independent

A Must Read - Share

AstraZeneca hit by patent expiries as sales slump

Drugmaker AstraZeneca has showed it is still languishing in intensive care after patent expiries triggered an 8 per per cent fall in sales to $25.7     

Tags: AstraZeneca hit by patent expiries as sales slump,  Astrazeneca Latest News